PubMed

Antiemetic efficacy of high-dose dexamethasone in induction therapy in acute nonlymphocytic leukemia.

Cassileth PA, Lusk EJ, Torri S, Gerson SL.

Ann Intern Med. 1984 May;100(5):701-2. No abstract available. PMID: 6712035 [PubMed - indexed for MEDLINE]Related articles

Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.

Numbenjapon T, Sriswasdi C, Mongkonsritragoon W, Leelasiri A, Prayoonwiwat W.

J Med Assoc Thai. 2002 Nov;85(11):1156-63.PMID: 12546311 [PubMed - indexed for MEDLINE]Related articles

Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.

Lofters WS, Pater JL, Zee B, Dempsey E, Walde D, Moquin JP, Wilson K, Hoskins P, Guevin RM, Verma S, Navari R, Krook JE, Hainsworth J, Palmer M, Chin C.

J Clin Oncol. 1997 Aug;15(8):2966-73.PMID: 9256141 [PubMed - indexed for MEDLINE]Related articles

Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. Italian Group for Antiemetic Research.

[No authors listed]

J Clin Oncol. 1995 Sep;13(9):2417-26.PMID: 7666102 [PubMed - indexed for MEDLINE]Related articles

Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.

Lindley C, Goodin S, McCune J, Kane M, Amamoo MA, Shord S, Pham T, Yowell S, Laliberte K, Schell M, Bernard S, Socinski MA.

Am J Clin Oncol. 2005 Jun;28(3):270-6.PMID: 15923800 [PubMed - indexed for MEDLINE]Related articles

Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.

Hulstaert F, Van Belle S, Bleiberg H, Canon JL, Dewitte M, Buyse M, De Keyser P, Westelinck KJ.

J Clin Oncol. 1994 Nov;12(11):2439-46.PMID: 7964961 [PubMed - indexed for MEDLINE]Related articles

A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.

Sorbe BG, Berglind AM, Andersson H, Boman K, Högberg T, Hallgren M, Schmidt M.

Cancer. 1998 Sep 1;83(5):1022-32.PMID: 9731907 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.

Birch R, Weaver CH, Carson K, Buckner CD.

Bone Marrow Transplant. 1998 Oct;22(7):685-8.PMID: 9818697 [PubMed - indexed for MEDLINE]Related articlesFree article

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.

Hesketh PJ, Grunberg SM, Gralla RJ, Warr DG, Roila F, de Wit R, Chawla SP, Carides AD, Ianus J, Elmer ME, Evans JK, Beck K, Reines S, Horgan KJ; Aprepitant Protocol 052 Study Group.

J Clin Oncol. 2003 Nov 15;21(22):4112-9. Epub 2003 Oct 14.PMID: 14559886 [PubMed - indexed for MEDLINE]Related articles

Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.

Hesketh PJ, Beck T, Uhlenhopp M, Kris MG, Hainsworth JD, Harker WG, Cohen JR, Lester E, Kessler JF, Griffen D, et al.

J Clin Oncol. 1995 Aug;13(8):2117-22.PMID: 7636556 [PubMed - indexed for MEDLINE]Related articles

Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.

Sorbe BG.

Semin Oncol. 1994 Oct;21(5 Suppl 9):20-6.PMID: 9113123 [PubMed - indexed for MEDLINE]Related articles

Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. The Italian Group for Antiemetic Research.

[No authors listed]

N Engl J Med. 1995 Jan 5;332(1):1-5.PMID: 7990859 [PubMed - indexed for MEDLINE]Related articlesFree article

Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.

Gralla RJ, Navari RM, Hesketh PJ, Popovic W, Strupp J, Noy J, Einhorn L, Ettinger D, Bushnell W, Friedman C.

J Clin Oncol. 1998 Apr;16(4):1568-73.PMID: 9552067 [PubMed - indexed for MEDLINE]Related articles

Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.

Perez EA, Lembersky B, Kaywin P, Kalman L, Yocom K, Friedman C.

Cancer J Sci Am. 1998 Jan-Feb;4(1):52-8.PMID: 9467047 [PubMed - indexed for MEDLINE]Related articles

Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.

Hajdenberg J, Grote T, Yee L, Arevalo-Araujo R, Latimer LA.

J Support Oncol. 2006 Oct;4(9):467-71.PMID: 17080735 [PubMed - indexed for MEDLINE]Related articles

Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.

Campora E, Giudici S, Merlini L, Rubagotti A, Rosso R.

Am J Clin Oncol. 1994 Dec;17(6):522-6.PMID: 7977174 [PubMed - indexed for MEDLINE]Related articles

Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.

Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM.

Zhonghua Yi Xue Za Zhi (Taipei). 2000 Oct;63(10):729-36.PMID: 11076429 [PubMed - indexed for MEDLINE]Related articles

Granisetron plus dexamethasone in moderately emetogenic chemotherapy: evaluation of activity during three consecutive courses of chemotherapy.

Silva RR, Bascioni R, Giorgi F, Acito L, Giustini L, De Signoribus G, Marcellini M, Menichetti ET, Giuliodori L.

Support Care Cancer. 1996 Jul;4(4):287-90.PMID: 8829306 [PubMed - indexed for MEDLINE]Related articles

The use of dexamethasone (Hexadrol) as an antiemetic in association with chemotherapy for neoplastic disease.

Gathercole F, Connolly N, Birdsell J.

Oncol Nurs Forum. 1982 Summer;9(3):17-9. No abstract available. PMID: 6921787 [PubMed - indexed for MEDLINE]Related articles

Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.

Abbott B, Ippoliti C, Bruton J, Neumann J, Whaley R, Champlin R.

Bone Marrow Transplant. 1999 Feb;23(3):265-9.PMID: 10084258 [PubMed - indexed for MEDLINE]Related articlesFree article